Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
Reset all filters
01 1FARMAK, a.s
02 1Biophore India Pharmaceuticals Pvt Ltd
03 1Transo-Pharm USA LLC
04 1Anax Laboratories
05 1Apicore
06 1BrightGene Bio-Medical Technology Co.,Ltd
07 1Curia
08 2GLAND PHARMA LIMITED
09 1Hetero Drugs
10 1MSN Laboratories
11 1Nanjing Heron Pharmaceutical
12 1SKVen Technologies Pvt. Ltd
13 1ScinoPharm Taiwan, Ltd
14 1Sionc Pharmaceuticals
15 1Sun Pharmaceutical Industries Limited
16 1USV Private Limited
17 1Viatris
18 1Wockhardt
19 1Zhuhai Rundu Pharmaceutical
Reset all filters
01 3China
02 1Czech Republic
03 12India
04 1Taiwan
05 3U.S.A
Reset all filters
01 12Active
02 8Blank
01 20Blank
Reset all filters
01 20Blank
Reset all filters
01 1WC-0273
02 1WC-0427
03 18Blank
Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-02-18
Pay. Date : 2021-01-13
DMF Number : 35433
Submission : 2021-01-04
Status : Active
Type : II
NDC Package Code : 63278-1068
Start Marketing Date : 2010-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-12-08
Pay. Date : 2016-09-16
DMF Number : 30834
Submission : 2016-09-13
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-10-16
Pay. Date : 2015-08-27
DMF Number : 28939
Submission : 2014-12-25
Status : Active
Type : II
NDC Package Code : 65129-1331
Start Marketing Date : 2015-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36679
Submission : 2022-01-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36338
Submission : 2021-11-26
Status : Active
Type : II
NDC Package Code : 69766-103
Start Marketing Date : 2021-11-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-08-24
Pay. Date : 2015-06-24
DMF Number : 29315
Submission : 2015-06-23
Status : Active
Type : II
NDC Package Code : 62147-0220
Start Marketing Date : 2019-12-24
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-12-08
Pay. Date : 2017-03-27
DMF Number : 31539
Submission : 2017-11-24
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-09-30
Pay. Date : 2015-03-31
DMF Number : 29185
Submission : 2015-03-31
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-12-04
Pay. Date : 2018-09-14
DMF Number : 32339
Submission : 2018-01-07
Status : Active
Type : II
10
PharmaCompass offers a list of Regadenoson Monohydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Regadenoson Monohydrate manufacturer or Regadenoson Monohydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Regadenoson Monohydrate manufacturer or Regadenoson Monohydrate supplier.
PharmaCompass also assists you with knowing the Regadenoson Monohydrate API Price utilized in the formulation of products. Regadenoson Monohydrate API Price is not always fixed or binding as the Regadenoson Monohydrate Price is obtained through a variety of data sources. The Regadenoson Monohydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Regadenoson Monohydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Regadenoson Monohydrate, including repackagers and relabelers. The FDA regulates Regadenoson Monohydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Regadenoson Monohydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Regadenoson Monohydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Regadenoson Monohydrate supplier is an individual or a company that provides Regadenoson Monohydrate active pharmaceutical ingredient (API) or Regadenoson Monohydrate finished formulations upon request. The Regadenoson Monohydrate suppliers may include Regadenoson Monohydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Regadenoson Monohydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
We have 19 companies offering Regadenoson Monohydrate
Get in contact with the supplier of your choice: